article thumbnail

Value-Based Health Care Needs All Stakeholders at the Table – Especially the Patient

Health Populi

The coolest thing in health policy in the 21st century!! ” Amitabh Chandra gave the opening context-setting talk about the effects of health care cost-sharing on patients-as-consumers. Kavita Patel to assert in the first panel of the day that, “2713 is my favorite number.”

article thumbnail

Will Technology Cure Americans’ Health Care System Ills? Considering Google and Ascension Health’s Data Deal

Health Populi

You can read more details about this evolving situation in the WSJ article linked above, and other takes in tech, business, and social media that have begun to populate the interwebs. health care. Was this due to the growing experience and reporting of surprise medical bills?

BioTech 160
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

Health Populi

It is bittersweet to read the latter half of the title, as our friend and mentor Professor Reinhardt, a health economics pioneer, passed away last year. He co-wrote the first “It’s The Prices Stupid” research article in Health Affairs with Gerard Anderson et. Two news items illustrate this issue in real time.

BioTech 160
article thumbnail

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Health Populi

When this occurred, it didn’t cause more than a ripple of interest outside biotech. Jane Sarasohn-Kahn Bio and her Blog, Health Populi. To address that challenge, in 2017 PLM secured a $100 million (controlling interest) investment from iCarbonX , a Chinese company that is amassing patient data to discover cures for disease.

article thumbnail

Prescription Drug Costs In America Through the Patient Lens, via IQVIA, GoodRx and a New $2 Million Therapy

Health Populi

Yesterday’s Wall Street Journal featured an article on A $2 Million Therapy About to Hit [the] Market , discussing a new gene therapy treatment that addresses spinal muscular atrophy (SMA).

Medicare 149
article thumbnail

The Remarkable Rise of Pharma’s Reputation in the Pandemic

Health Populi

Beth writes that, “a whopping two-thirds of Americans now offer a thumbs-up on pharma” as the title of her article, calling out the 30-point gain from 32% in January 2020 to 62% in February 2021. consumers trusted the biotech health industry segment compared with the pharmaceutical segment. Why was this the case?

article thumbnail

Americans Across Political Party Worry About Prescription Drug Prices – Especially to Deal with COVID-19

Health Populi

The New England Journal of Medicine published an essay on June 4, 2020, titled, Specialty Drugs–A Distinctly American Phenomenon (my apologies–the article is behind the NEJM paywall). The phrase “specialty drugs” originated in the 1970s in the advent of injectable and infusion therapies.

BioTech 191